Micreos Group
PrivateLast Round
Series D
Oct 25, 2022
Total Funding Raised
$61.65M
Company Overview
Micreos Group operates in Healthcare & Life Sciences and is based in the Netherlands. Its latest recorded funding round was a Series D round in October 2022.
Micreos Group is a biotechnology company that develops targeted antibacterial products based on phage and endolysin technology to replace antibiotics in human health, food safety, and animal health applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micreos Group Comparables
Compare Micreos Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lysando AG | 79% | |
| BioNTech SE | 71% | |
| Intralytix, Inc. | 70% |
For institutional investors. Book with your work email.
Micreos Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 25, 2022 | ||||
| Series D | Sep 30, 2021 | ||||
| VC Round | Mar 29, 2019 | ||||
| VC Round | Feb 18, 2016 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2022
$25M round closed.
- Mar 29, 2019
$34M round raised.
For institutional investors. Book with your work email.
Micreos Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Micreos Group's valuation, stock price, and market status.
Is Micreos Group a public or private company?
Micreos Group is a private company.
What is the current stock price of Micreos Group?
Micreos Group is a private company, so its shares have no public market price. Caplight tracks Micreos Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Micreos Group worth (valuation)?
Valuation information for Micreos Group is not publicly available.
Can I buy Micreos Group stock?
Micreos Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Micreos Group's last funding round?
Micreos Group's most recent funding round was Series D on October 25, 2022.
Who are the main investors in Micreos Group?
Investor information for Micreos Group is not publicly disclosed.
Will Micreos Group IPO soon?
No public IPO plans have been announced for Micreos Group.
How can I track Micreos Group secondary market activity?
Caplight tracks bids, offers, and trades in Micreos Group's shares on secondary markets.